Chemomab Therapeutics Ltd. (CMMB) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-11
1:04 pm
Purchase
2025-08-1113GGalecto, Inc.
GLTO
Otto Erik1,690,000
8.100%
1,690,000increase
(New Position)
Filing
History
2025-08-07
4:21 pm
Sale
2025-07-3113GChemomab Therapeutics Ltd.
CMMB
MORGAN STANLEY
MS
3,303,315
3.200%
-4,767,355decrease
(-59.07%)
Filing
History
2025-08-07
11:45 am
Purchase
2025-06-3013GChemomab Therapeutics Ltd.
CMMB
MORGAN STANLEY
MS
8,070,670
8.400%
8,070,670increase
(New Position)
Filing
History
2025-06-23
5:06 pm
Sale
2025-06-1813DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership242,452
4.800%
-222,775decrease
(-47.89%)
Filing
History
2025-04-10
5:25 pm
Sale
2025-03-3113GChemomab Therapeutics Ltd.
CMMB
SPHERA FUNDS MANAGEMENT LTD.225,107
4.780%
-78,537decrease
(-25.86%)
Filing
History
2024-11-29
3:04 pm
Purchase
2024-11-1413DChemomab Therapeutics Ltd.
CMMB
Mor George Adi224,555
4.800%
37,694increase
(+20.17%)
Filing
History
2024-11-21
10:59 am
Purchase
2024-11-2113GChemomab Therapeutics Ltd.
CMMB
Otto Erik288,750
6.100%
288,750increase
(New Position)
Filing
History
2024-09-16
4:34 pm
Sale
2024-09-1213DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership465,227
9.990%
-102,296decrease
(-18.03%)
Filing
History
2024-08-20
2:36 pm
Purchase
2024-07-2513GChemomab Therapeutics Ltd.
CMMB
SPHERA FUNDS MANAGEMENT LTD.303,644
6.560%
303,644increase
(New Position)
Filing
History
2024-03-11
7:19 pm
Unchanged
2024-03-1113DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership567,523
16.000%
0
(Unchanged)
Filing
History
2023-11-15
4:35 pm
Unchanged
2023-11-1413DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership567,523
18.300%
0
(Unchanged)
Filing
History
2023-01-05
4:31 pm
Sale
2023-01-0313DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership567,523
19.700%
-12,467,432decrease
(-95.65%)
Filing
History
2022-11-17
4:40 pm
Sale
2022-11-1613DChemomab Therapeutics Ltd.
CMMB
Mor George Adi186,861
6.400%
-145,506decrease
(-43.78%)
Filing
History
2022-02-10
4:02 pm
Sale
2021-12-3113GANCHIANO THERAPEUTICS LTD
ANCN
Gabriel Capital Management Ltd.3,087,040
1.400%
-5,781,506decrease
(-65.19%)
Filing
History
2022-01-20
06:01 am
Purchase
2021-03-1613DChemomab Therapeutics Ltd.
CMMB
Mor George Adi332,367
11.500%
332,367increase
(New Position)
Filing
History
2021-04-15
5:28 pm
Purchase
2021-03-1613DChemomab Therapeutics Ltd.
CMMB
Access Industries Holdings LLC1,264,442
2.360%
1,264,442increase
(New Position)
Filing
History
2021-03-26
4:06 pm
Purchase
2021-03-1613DChemomab Therapeutics Ltd.
CMMB
OrbiMed Israel BioFund GP Limited Partnership13,034,955
24.300%
13,034,955increase
(New Position)
Filing
History
2021-03-26
08:10 am
Purchase
2021-03-1613GChemomab Therapeutics Ltd.
CMMB
PETER THIEL5,657,815
10.600%
5,657,815increase
(New Position)
Filing
History
2020-12-21
4:31 pm
Unchanged
2020-12-1413DANCHIANO THERAPEUTICS LTD
ANCN
Access Industries Holdings LLC15,829,397
42.700%
0
(Unchanged)
Filing
History
2020-12-17
5:36 pm
Sale
2020-12-1713DANCHIANO THERAPEUTICS LTD
ANCN
Palisade Medical Equity I LP0
0.000%
-1,848,200decrease
(Position Closed)
Filing
History